GlassScriptPhysician profile
Aileen Padilla
NPI 1013394162
$73,302.69
in general payments reported to CMS, 2019-2025
35 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $838 · 2021: $2,076 · 2022: $2,791 · 2023: $10K · 2024: $18K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Travel and Lodging: $16K · Food and Beverage: $9,745 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,671.22 |
| Travel and Lodging | $15,563.44 |
| Food and Beverage | $9,744.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,618.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $27,353.93 | 2021-2025 | Intellis Adaptivestim, Accurian, Synchromedii |
| Vertos Medical, INC. | $19,458.80 | 2021-2024 | Mild Device Kit |
| Stryker Corporation | $12,323.60 | 2024-2025 | Mild Device Kit, Spinejack, Augment Injectable |
| Boston Scientific Corporation | $4,697.61 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Relievant Medsystems, INC. | $3,026.70 | 2020-2023 | Intracept |
| Mml US, INC. | $1,864.20 | 2022 | |
| Abbott Laboratories | $967.70 | 2021-2023 | Proclaim |
| Nevro Corp. | $548.45 | 2023-2024 | Senza |
| Abbvie INC. | $470.16 | 2021-2025 | |
| Spinal Simplicity, LLC | $258.02 | 2024-2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $247.57 | 2025 | Senza, Vyrsa V1 |
| Nalu Medical, INC. | $175.50 | 2023-2024 | Nalu Neurostimulation System |
| Brixton Biosciences, INC. | $159.78 | 2025 | Neural Ice |
| Allergan, INC. | $152.08 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $138.43 | 2021-2023 | Ajovy |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $133.27 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $127.74 | 2021 | |
| Zimmer Biomet Holdings, INC. | $125.00 | 2022 | |
| Si-Bone, INC. | $107.14 | 2025 | |
| Medtronic USA, INC. | $102.20 | 2020 | |
| Painteq LLC | $100.35 | 2023 | Painteq |
| Collegium Pharmaceutical, INC. | $87.32 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $87.29 | 2020-2023 | Ztlido |
| Radius Health, INC. | $84.42 | 2020-2021 | |
| Merz Pharmaceuticals, LLC | $76.47 | 2025 | Xeomin |
| Amgen INC. | $76.13 | 2021-2022 | |
| Bioventus LLC | $65.89 | 2025 | Durolane, Xcell |
| Curonix LLC | $64.19 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.98 | 2024-2025 | Relistor |
| Mvp Orthopedics INC | $54.99 | 2021-2022 | |
| Fidia Pharma USA INC. | $37.07 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $20.00 | 2025 | |
| Spr Therapeutics, INC | $18.42 | 2024 | Sprint Pns System |
| Masimo Corporation | $16.93 | 2024 | Set and Rainbow Set |
| Redhill Biopharma INC. | $15.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aileen Padilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.